Exclusion criteria:
|
1. Patients with nephrotic syndrome, hypothyroidism, renal failure, liver disease, systemic lupus erythematosus, myeloma, glycogen accumulation, lipoatrophy, acute porphyria and polycystic ovary syndrome.
2. Patients who are using drugs related to blood lipid metabolism, such as diuretics, beta blockers, glucocorticoids, metformin, insulin, contraceptive.
3. Patients with systolic blood pressure ≥ 180mmHg or diastolic blood pressure ≥ 110mHg after treatment.
4. Patients whose fasting blood glucose was still ≥ 11.1mmol/L after oral drug treatment.
5. Patients whose TG ≥ 5.65mmol/L.
6. Patients with systemic severe diseases such as heart, liver, kidney, hematopoietic system, immune system, etc.
7. Pregnant or lactating women or people who plan to become pregnant during the trial or whose spouse plans to become pregnant.
8. Patients with allergic constitution, who may be allergic to this drug or who are mentally ill.
9. Other patients who can't cooperate for a long time.
|